Abiopharma

BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder

BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder

FreightCar America, Inc. Joins Russell 2000® and Russell 3000® Indexes

Valmont Releases 2026 Sustainability Report

Streamex Corp. Brings Yield-Bearing Gold (GLDY) to Traditional Brokerage Accounts Through Collaboration with Siebert Financial and tZERO

Almonty Industries Joins Large-Cap Russell 1000® Index and Broad-Market Russell 3000® Index

FuelCell Energy Secures $49 Million in EXIM Financing to Advance U.S. Clean Energy Exports

HONEYWELL TECHNOLOGIES TO RELEASE SECOND QUARTER FINANCIAL RESULTS, DISCUSS 2026 OUTLOOK AND HOLD ITS INVESTOR CONFERENCE CALL ON THURSDAY, JULY 23

Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer

Palvella Therapeutics Submits First Module of Rolling New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations